These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT. Van de Vijver E, Desager K, Mulberg AE, Staelens S, Verkade HJ, Bodewes FA, Malfroot A, Hauser B, Sinaasappel M, Van Biervliet S, Behm M, Pelckmans P, Callens D, Veereman-Wauters G. J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537 [Abstract] [Full Text] [Related]
24. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis. Littlewood JM, Wolfe SP, Conway SP. Pediatr Pulmonol; 2006 Jan; 41(1):35-49. PubMed ID: 16288483 [Abstract] [Full Text] [Related]
25. Romanian guidelines on the diagnosis and treatment of exocrine pancreatic insufficiency. Gheorghe C, Seicean A, Saftoiu A, Tantau M, Dumitru E, Jinga M, Negreanu L, Mateescu B, Gheorghe L, Ciocirlan M, Cijevschi C, Constantinescu G, Dima S, Diculescu M, Romanian Association for Pancreatic Pathology. J Gastrointestin Liver Dis; 2015 Mar; 24(1):117-23. PubMed ID: 25822444 [Abstract] [Full Text] [Related]
26. Liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis. Borowitz D, Stevens C, Brettman LR, Campion M, Wilschanski M, Thompson H, Liprotamase 767 Study Group. J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):248-57. PubMed ID: 22266487 [Abstract] [Full Text] [Related]
27. Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment. Bruno MJ, Haverkort EB, Tytgat GN, van Leeuwen DJ. Am J Gastroenterol; 1995 Sep; 90(9):1383-93. PubMed ID: 7661155 [Abstract] [Full Text] [Related]
29. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway. Dorlöchter L, Aksnes L, Fluge G. Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582 [Abstract] [Full Text] [Related]
30. Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey. Sikkens EC, Cahen DL, van Eijck C, Kuipers EJ, Bruno MJ. Pancreatology; 2012 Aug; 12(1):71-3. PubMed ID: 22487479 [Abstract] [Full Text] [Related]
31. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage? Lankisch PG, Lembcke B, Göke B, Creutzfeldt W. Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109 [Abstract] [Full Text] [Related]
32. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy]. Löser C, Fölsch UR. Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011 [Abstract] [Full Text] [Related]
33. Pancreatic Exocrine Insufficiency as a Complication of Gastrointestinal Surgery and the Impact of Pancreatic Enzyme Replacement Therapy. Chaudhary A, Domínguez-Muñoz JE, Layer P, Lerch MM. Dig Dis; 2020 Mar; 38(1):53-68. PubMed ID: 31422398 [Abstract] [Full Text] [Related]
34. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Stern RC, Eisenberg JD, Wagener JS, Ahrens R, Rock M, doPico G, Orenstein DM. Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038 [Abstract] [Full Text] [Related]
35. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. De Boeck K, Weren M, Proesmans M, Kerem E. Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171 [Abstract] [Full Text] [Related]
36. Metabolic markers of protein maldigestion after a 15N test meal in minipigs with pancreatic exocrine insufficiency. Mary F, Moesseler A, Khodorova N, Foucault-Simonin A, Benamouzig R, Tomé D, Gregory PC, Gaudichon C. Am J Physiol Gastrointest Liver Physiol; 2018 Feb 01; 314(2):G223-G230. PubMed ID: 29074486 [Abstract] [Full Text] [Related]
37. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis. Heijerman HG. Neth J Med; 1992 Oct 01; 41(3-4):105-9. PubMed ID: 1470278 [Abstract] [Full Text] [Related]
38. Pancreatic exocrine insufficiency in HIV-positive patients. Price DA, Schmid ML, Ong EL, Adjukeiwicz KM, Peaston B, Snow MH. HIV Med; 2005 Jan 01; 6(1):33-6. PubMed ID: 15670250 [Abstract] [Full Text] [Related]
39. Gastric acid suppression and treatment of severe exocrine pancreatic insufficiency. DiMagno EP. Best Pract Res Clin Gastroenterol; 2001 Jun 01; 15(3):477-86. PubMed ID: 11403540 [Abstract] [Full Text] [Related]
40. Pancreatic enzyme pharmacotherapy. Ferrone M, Raimondo M, Scolapio JS. Pharmacotherapy; 2007 Jun 01; 27(6):910-20. PubMed ID: 17542772 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]